|
| 回到 StockQ 正常版首頁 |
法盛新興歐洲股票基金 R/A
| ||||||||||||
| 年度報酬率 |
| 2018 | 2019 | 2020 | 2021 | 2022 | |
| 淨值 | -13.10% | 29.76% | -8.58% | 8.94% | -41.10% |
| 含息 | -13.10% | 29.76% | -8.58% | 8.94% | -41.10% |
| 法盛新興歐洲股票基金 R/A |
| 日期 | 淨值 | 漲跌比例 |
| 2023/05/25 | 45.6900 | -0.50% |
| 2023/05/24 | 45.9200 | -1.42% |
| 2023/05/23 | 46.5800 | -0.70% |
| 2023/05/22 | 46.9100 | 0.73% |
| 2023/05/19 | 46.5700 | -0.34% |
| 2023/05/17 | 46.7300 | -0.38% |
| 2023/05/16 | 46.9100 | -0.49% |
| 2023/05/15 | 47.1400 | -2.92% |
| 2023/05/12 | 48.5600 | 0.25% |
| 2023/05/11 | 48.4400 | 1.28% |
基金績效 (可點按欄位名稱排序)
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 法盛新興歐洲股票基金 R/A/美元 | 6.95% | 6.16% | 14.86% | 2.03% |
| 俄羅斯指數 | 12.47% | -5.72% | -6.15% | 9.64% |
| MSCI 新興歐洲指數 (price) | 0.65% | 12.74% | 19.06% | 6.62% |
| MSCI 新興東歐指數 (price) | 8.84% | 21.15% | 11.18% | 15.91% |
| MSCI 俄羅斯指數 (price) | 0.00% | 0.00% | 0.00% | 0.00% |
| 霸菱東歐基金-A類/配息/歐元 | -48.68% | -49.49% | -42.71% | -48.19% |
| 霸菱東歐基金-A類/配息/美元 | -49.04% | -51.90% | -47.00% | -48.74% |
| 貝萊德新興歐洲基金A2/歐元 | -58.54% | -59.46% | -51.04% | -58.97% |
| 貝萊德新興歐洲基金A2/美元 | -58.79% | -61.34% | -54.67% | -59.40% |
| 法巴新興歐洲股票基金-C股/美元 | -53.37% | -57.03% | -50.79% | -54.01% |
| 法巴新興歐洲股票基金-年配/歐元 | -53.02% | -54.90% | -49.20% | -53.43% |
| 法巴新興歐洲股票基金-C股/歐元 | -53.02% | -54.90% | -46.82% | -53.43% |
| 富蘭克林坦伯頓東歐基金-A/累積/美元 | 10.89% | 20.10% | N/A% | 13.25% |
| 富蘭克林坦伯頓東歐基金-A/累積/歐元 | 8.98% | 16.42% | N/A% | 12.93% |
| NN(L)歐洲新興市場股票基金-X股/歐元 | -44.27% | -46.72% | -37.83% | -45.75% |
| NN(L)歐洲新興市場股票基金-X股/美元 | -44.68% | -49.22% | -42.86% | -46.41% |
| 法盛新興歐洲股票基金 R/D/美元 | 6.94% | 4.23% | 12.78% | 0.20% |
| 法盛新興歐洲股票基金 R/A/歐元 | 5.96% | 2.97% | 14.35% | 1.52% |
| 鋒裕匯理-新興歐洲及地中海股票基金-A2/美元 | N/A% | N/A% | N/A% | N/A% |
| 鋒裕匯理-新興歐洲及地中海股票基金-B2/美元 | N/A% | N/A% | N/A% | N/A% |
| 鋒裕匯理-新興歐洲及地中海股票基金-A2/歐元 | N/A% | N/A% | N/A% | N/A% |
| 鋒裕匯理-新興歐洲及地中海股票基金-B2/歐元 | N/A% | N/A% | N/A% | N/A% |
| 施羅德新興歐洲基金-A1/累積/歐元 | 6.70% | 19.00% | N/A% | 17.99% |
| 施羅德新興歐洲基金-A1/累積/美元 | 7.52% | 23.46% | N/A% | 18.65% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|